APONTIS PHARMA AG |
Market Closed -
Other stock markets
|
After market 12:19:25 am | |||
| 8.5 EUR | -0.47% |
|
8.49 | -0.12% |
| 05/04 | Apontis Bags Distribution Deal with Novartis Unit for Two Asthma Medications | MT |
| 28/03 | Apontis Pharma AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar Apontis Pharma AG
0959fb75c28299767b748da6c30a288._s2YjEUtyW60wkwYeVQ-2wOl7pfjZoPRkyjlG3j3eqs.zoGg4RcAjwPbmAZ9EDhP7EjVgNSpUvS10EKmeDzBMOi2iKz0Mn_-XNynPw~922339c1b2c8dc66c502be1fdc0f8613
Upcoming events on Apontis Pharma AG
Past events on Apontis Pharma AG
| 17/05/2024 | Annual General Meeting |
| 13/05/2024 | German Spring Conference |
| 08/05/2024 02:30 pm | Q1 2024 Earnings Call |
| 08/05/2024 11:00 am | Q1 2024 Earnings Release |
| 10/04/2024 | Roadshow - Montega |
| 04/04/2024 | Investor Meeting |
| 28/03/2024 04:00 pm | Q4 2023 Earnings Call |
| 28/03/2024 12:00 pm | Q4 2023 Earnings Release |
| 09/11/2023 02:30 pm | Q3 2023 Earnings Call |
| 09/11/2023 12:00 pm | Q3 2023 Earnings Release |
| 04/09/2023 | German Fall Conference |
| 23/08/2023 | Hamburg Investor Day |
| 10/08/2023 12:30 pm | Q2 2023 Earnings Call |
| 10/08/2023 11:00 am | Q2 2023 Earnings Release |
| 10/07/2023 | Extraordinary Shareholders Meeting |
| 15/05/2023 | Equity Forum Spring Conference |
| 12/05/2023 01:30 pm | Annual General Meeting |
| 09/05/2023 12:30 pm | Q1 2023 Earnings Call |
| 09/05/2023 11:00 am | Q1 2023 Earnings Release |
| 04/04/2023 | Investor Meeting |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 39,2 | 51,2 51,2 -0.03% | 55,7 55,6 0.17% | 37,0 35,9 3.06% | 51,2 |
|
EBITDA Million EUR | Released Forecast Spread | 0,00 | 4,86 5,90 -17.59% | 5,57 5,63 -1.14% | -13,3 -13,8 3.54% | 3,68 |
|
EBIT Million EUR | Released Forecast Spread | 0,00 | 3,12 2,45 27.18% | 3,88 3,87 0.24% | -15,2 -15,8 4.03% | 1,66 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 0,00 | 0,25 1,75 -85.81% | 3,83 3,73 2.53% | -14,8 -16,0 7.02% | 1,75 |
|
Net income Million EUR | Released Forecast Spread | -1,18 | -0,75 1,35 -155.2% | 2,69 2,77 -2.82% | -11,3 -14,7 23.28% | 1,26 |
|
EPS EUR | Released Forecast Spread | 0,00 | -0,09 0,17 -153.33% | 0,32 0,32 -2.17% | -1,33 -1,74 23.57% | 0,15 |
| Announcement Date | 29/04/21 | 30/03/22 | 30/03/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 S1 | 2022 S1 | 2022 Q3 | 2024 Q1 | 2024 Q2 |
|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 24,0 | 10,5 | 9,80 | ||
|
EBITDA Million EUR | Released Forecast Spread | 1,40 | 0,90 | |||
|
EBIT Million EUR | Released Forecast Spread | 1,20 | ||||
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 2,39 | ||||
|
Net income Million EUR | Released Forecast Spread | -2,20 | 2,35 | |||
| Announcement Date | 11/08/21 | 11/08/22 | - | - | - |
More events
Past sector events for Apontis Pharma AG
| 21/06/2024 08:58 pm | DEVA HOLDING: Q1 2024 Earnings Release |
| 14/06/2024 02:51 am | EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release |
| 11/06/2024 11:00 am | BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release |
| 07/06/2024 04:03 pm | SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release |
| 07/06/2024 02:47 pm | LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release |
| 30/05/2024 05:38 pm | SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 30/05/2024 04:30 pm | ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release |
| 30/05/2024 11:54 am | MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release |
| 29/05/2024 05:30 pm | FDC LIMITED: Q4 2024 Earnings Release |
| 29/05/2024 02:56 pm | JUBILANT PHARMOVA LIMITED: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- APPH Stock
- Calendar Apontis Pharma AG
